Interés Humano

Vacuna rusa: Finaliza fase de experimentación clínica de primera vacuna de Rusia contra covid-19

Fármaco demostró tener capacidad de crear inmunidad sin provocar efectos secundarios peligrosos para la salud

(FILES) In this file photo taken on March 26, 2020 a researcher works on virus replication in order to develop a vaccine against the coronavirus COVID-19, in Belo Horizonte, state of Minas Gerais, Brazil, on March 26, 2020. - Brazil said on June 27, 2020 it had reached a deal to produce up to 100 million doses of the coronavirus vaccine being developed by Oxford University, which the country is helping to test. The vaccine, which Oxford is working on with pharmaceuticals group AstraZeneca, is one of the most promising of the dozens that researchers worldwide are racing to test and bring to market. (Photo by Douglas MAGNO / AFP)
(FILES) In this file photo taken on March 26, 2020 a researcher works on virus replication in order to develop a vaccine against the coronavirus COVID-19, in Belo Horizonte, state of Minas Gerais, Brazil, on March 26, 2020. - Brazil said on June 27, 2020 it had reached a deal to produce up to 100 million doses of the coronavirus vaccine being developed by Oxford University, which the country is helping to test. The vaccine, which Oxford is working on with pharmaceuticals group AstraZeneca, is one of the most promising of the dozens that researchers worldwide are racing to test and bring to market. (Photo by Douglas MAGNO / AFP) DOUGLAS MAGNO
Brasil Un investigador trabaja en la replicación de covid-19 para desarrollar una vacuna, en Belo Horizonte, estado de Minas Gerais, Brasil, el 26 de marzo del 2020. Foto: AFP (DOUGLAS MAGNO/AFP)

La Universidad Séchenovski de Moscú, en Rusia, anunció este sábado que los ensayos de la primera vacuna rusa contra la covid-19 finalizaron de forma exitosa, según dio a conocer la agencia RIA.

“La Universidad Séchenovski ha completado con éxito las pruebas en voluntarios de la primera vacuna del mundo contra el coronavirus”, declaró Vadim Tarásov, director del Instituto de Medicina Traslacional y Biotecnología de la Universidad Séchenovski.

‌
‌

‌

‌
‌

‌

‌